xc221
Small moleculeexperimental
Clinical trial activity
9 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
6
Phase 3
3
Phase 4
0
Earliest trial started May 22, 2017 (NCT03459391)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06096571 | N/A | Jan 15, 2024 | Valenta Pharm JSC |
| NCT05544916 | Phase 3 | Aug 5, 2022 | Valenta Pharm JSC |
| NCT05295121 | Phase 1 | Feb 10, 2022 | Valenta Pharm JSC |
| NCT05030324 | Phase 2 | Oct 1, 2021 | Valenta Pharm JSC |
| NCT04940182 | Phase 3 | Jun 26, 2021 | Pharmenterprises LLC |
| NCT04487574 | Phase 3 | Jul 25, 2020 | Pharmenterprises LLC |
| NCT03830905 | Phase 2 | Jan 31, 2019 | Pharmenterprises LLC |
| NCT03455491 | Phase 2 | Feb 12, 2018 | Pharmenterprises LLC |
| NCT03459391 | Phase 1 | May 22, 2017 | Pharmenterprises LLC |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pharmenterprises LLC | For profit | 5 | 5 | 3 | 2017 |
| Valenta Pharm JSC | For profit | 4 | 4 | 4 | 2021 |
2 organizations
Page 1 / 1